2007
DOI: 10.1007/s00280-007-0465-0
|View full text |Cite
|
Sign up to set email alerts
|

Lysosomotropic acid ceramidase inhibitor induces apoptosis in prostate cancer cells

Abstract: These results provide evidence that treatment with molecules such as LCL204, which restore ceramide levels in PCa cells may serve as a new viable treatment option for PCa.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

5
70
0
1

Year Published

2008
2008
2019
2019

Publication Types

Select...
6
2
1

Relationship

0
9

Authors

Journals

citations
Cited by 76 publications
(76 citation statements)
references
References 40 publications
5
70
0
1
Order By: Relevance
“…Prominent examples are daunorubicin, etoposide and tamoxifen, which appear, at least in part, to act via ceramide-induced apoptosis [65,181,[202][203][204][205][206]. Further promising agents to treat cancer are inhibitors for enzymes that metabolize ceramide, such as ceramidase or glucosyl-transferase ( Figure 2) [207][208][209][210][211]. Ceramide itself is rather difficult to use as a drug because of its poor water solubility and rapid physiological degradation.…”
Section: Sphingolipid Biosynthesis In the Endoplasmic Reticulum: Enzymentioning
confidence: 99%
“…Prominent examples are daunorubicin, etoposide and tamoxifen, which appear, at least in part, to act via ceramide-induced apoptosis [65,181,[202][203][204][205][206]. Further promising agents to treat cancer are inhibitors for enzymes that metabolize ceramide, such as ceramidase or glucosyl-transferase ( Figure 2) [207][208][209][210][211]. Ceramide itself is rather difficult to use as a drug because of its poor water solubility and rapid physiological degradation.…”
Section: Sphingolipid Biosynthesis In the Endoplasmic Reticulum: Enzymentioning
confidence: 99%
“…We demonstrate here, using live-cell studies, that a cationic fluorescently labeled calixarene (NBDCalAm) acts as a lysosomotropic compound without any induction of cell death, unlike other previously described lysosomotropic compounds (21,22). Thus this NBDCalAm provides us with a novel, remarkable easy to use, exciting tool to investigate lysosomal function and kinetics in living cells over longer periods of time.…”
mentioning
confidence: 99%
“…Kanserli prostat hücrelerinde radyasyon terapisi sırasında seramidaz enzim düzeyinin arttığı ve bu artışın ilaç-la tedaviye ve radyasyon terapisine karşı direnç oluşturduğu tespit edilmiştir (12,18). Seramidaz enziminin baskılanmasının kanserli prostat hücrelerinde apoptozu uyardığı ve kanser büyümesini engellediği gösterilmiştir (19,20). Kanserli karaciğer hücrelerinde de benzer şekil-de seramidaz enzim aktivitesinin baskılanması-nın kanser ilaçlarına olan direnci azalttığı tespit edilmiştir (21).…”
Section: şEki̇lunclassified